Vizionfocus Inc.

TW:4771 Taiwan Medical Instruments & Supplies
Market Cap
$331.68 Million
NT$10.97 Billion TWD
Market Cap Rank
#15440 Global
#570 in Taiwan
Share Price
NT$187.50
Change (1 day)
+7.14%
52-Week Range
NT$166.50 - NT$215.50
All Time High
NT$357.69
Categories
Companies in Taiwan Medical Instruments & Supplies
About

Vizionfocus Inc. engages in the manufacturing of medical equipment in Taiwan, China, Japan, and the United States. It also manufactures mechanical equipment, optical instruments, and precision instruments; trades internationally; and provides other consulting services. In addition, the company engages in the research and development, design, development, production, and wholesale of contact lense… Read more

Vizionfocus Inc. (4771) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.059x

Based on the latest financial reports, Vizionfocus Inc. (4771) has a cash flow conversion efficiency ratio of 0.059x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$242.32 Million) by net assets (NT$4.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Vizionfocus Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)

This chart illustrates how Vizionfocus Inc. 's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Vizionfocus Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vizionfocus Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Steyr Motors AG
VI:4X0
 		N/A
Even Construtora e Incorporadora S.A
SA:EVEN3
 		0.000x
460930
KQ:460930
 		0.043x
Ultra Jaya Milk Industry Tbk
JK:ULTJ
 		0.087x
John Mattson Fastighetsforetagen AB
ST:JOMA
 		0.008x
PERMA-PIPE INTL HLDGS
F:MF3
 		N/A
Boryung Pharm
KO:003850
 		0.060x
Protara Therapeutics Inc
NASDAQ:TARA
 		-0.094x

Annual Cash Flow Conversion Efficiency for Vizionfocus Inc. (2020–2024)

The table below shows the annual cash flow conversion efficiency of Vizionfocus Inc. from 2020 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 NT$3.85 Billion NT$1.14 Billion 0.297x -36.91%
2023-12-31 NT$2.04 Billion NT$958.65 Million 0.471x +25.67%
2022-12-31 NT$2.02 Billion NT$757.76 Million 0.375x +74.26%
2021-12-31 NT$1.81 Billion NT$388.97 Million 0.215x +266.82%
2020-12-31 NT$1.29 Billion NT$75.81 Million 0.059x --